Tricuspid Valve Regurgitation clinical trials at UCSF

2 in progress, 1 open to eligible people

Tricuspid valve regurgitation occurs when the valve between the two right heart chambers leaks. UCSF is testing a new device called the Edwards PASCAL Transcatheter Repair System. This trial aims to see if it is safe and works well for people with severe symptoms.

Showing trials for

  • Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

    open to eligible people ages 18 years and up

    To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

    San Francisco, California and other locations

  • TRISCEND II Pivotal Trial

    Sorry, in progress, not accepting new patients

    Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system

    San Francisco, California and other locations

Our lead scientists for Tricuspid Valve Regurgitation research studies include .

Last updated: